Form 8-K - Current report:
SEC Accession No. 0001104659-20-024471
Filing Date
2020-02-25
Accepted
2020-02-25 07:31:25
Documents
14
Period of Report
2020-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm206508-2_8k.htm   iXBRL 8-K 28383
2 EXHIBIT 99.1 tm206508d2_ex99-1.htm EX-99.1 133637
6 GRAPHIC tm2065082d2_ex99-1img01.jpg GRAPHIC 5588
  Complete submission text file 0001104659-20-024471.txt   363482

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA insm-20200225.xsd EX-101.SCH 3180
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20200225_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20200225_pre.xml EX-101.PRE 22706
9 EXTRACTED XBRL INSTANCE DOCUMENT tm206508-2_8k_htm.xml XML 3494
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 20647365
SIC: 2834 Pharmaceutical Preparations